FDA
-
-
-
-
-
-
-
Biogen presents Phase 2 data on Alzheimer's drug diranersen at AAIC
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $130 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
Ionis reports positive zilganersen data for Alexander disease
-
-
-
-
-
-
-
Ionis announces changes to Board of Directors
-
-
-
-
-
-
-
BIOGEN publishes study results for high-dose nusinersen in Nature Medicine
-
-
-
-
-
-
-
GSK hepatitis B drug meets goals in phase 3 trials
-
329,191 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

